Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
10 studies found for:    VibeX
Show Display Options
Rank Status Study
1 Completed
Has Results
Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device
Condition: Rheumatoid Arthritis (RA)
Intervention: Device: VIBEX MTX
2 Recruiting A Multi-Center, Randomized, Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus or Corneal Ectasia After Refractive Surgery
Conditions: Keratoconus;   Corneal Ectasia
Interventions: Device: KXL System (15 mW/cm2);   Device: KXL System (30 mW/cm2);   Device: KXL System (45 mW/cm2);   Drug: riboflavin ophthalmic solution
3 Completed
Has Results
Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device
Condition: Rheumatoid Arthritis (RA)
Intervention: Drug: MTX
4 Recruiting Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
Condition: Keratoconus
Interventions: Drug: riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system;   Drug: placebo: 0.0% riboflavin ophthalmic solution with the KXL system
5 Recruiting Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
Condition: Keratoconus
Interventions: Drug: riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system;   Drug: Placebo: 0.0% riboflavin ophthalmic solution with the KXL system
6 Withdrawn Safety and Efficacy Study for Corneal Collagen Cross-Linking in Eyes With Corneal Ectasia After Refractive Surgery
Condition: Corneal Ectasia
Interventions: Drug: riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system;   Drug: placebo: 0.0% riboflavin ophthalmic solution with the KXL system
7 Active, not recruiting A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Condition: Keratoconus
Interventions: Drug: riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system;   Drug: placebo: 0.0% riboflavin opthalmic solution with the KXL system
8 Completed
Has Results
Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration
Condition: Rheumatoid Arthritis
Intervention: Drug: Methotrexate (MTX)
9 Recruiting Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus
Condition: Keratoconus
Interventions: Drug: riboflavin ophthalmic solution;   Device: Vedera KXS Microwave System
10 Enrolling by invitation Simultaneous TransPRK and Corneal Collagen Cross-Linking
Condition: Keratoconus
Interventions: Procedure: Transepithelial Photorefractive Keratectomy (TransPRK);   Procedure: Corneal Collagen Cross-Linking (CXL)

Indicates status has not been verified in more than two years